Pneumococcal Conjugate Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Pneumococcal Conjugate Vaccine (PCV) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pneumococcal Conjugate Vaccine (PCV) Overall Market Size
2.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size: 2021 VS 2028
2.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pneumococcal Conjugate Vaccine (PCV) Players in Global Market
3.2 Top Global Pneumococcal Conjugate Vaccine (PCV) Companies Ranked by Revenue
3.3 Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Companies
3.4 Top 3 and Top 5 Pneumococcal Conjugate Vaccine (PCV) Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pneumococcal Conjugate Vaccine (PCV) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pneumococcal Conjugate Vaccine (PCV) Players in Global Market
3.6.1 List of Global Tier 1 Pneumococcal Conjugate Vaccine (PCV) Companies
3.6.2 List of Global Tier 2 and Tier 3 Pneumococcal Conjugate Vaccine (PCV) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Pneumococcal Conjugate Vaccine (PCV) Market Size Markets, 2021 & 2028
4.1.2 23-valent Vaccine
4.1.3 10-valent Vaccine
4.1.4 7-valent Vaccine
4.1.5 13-valent Vaccine
4.2 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
4.2.1 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2022
4.2.2 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2023-2028
4.2.3 By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Market Size, 2021 & 2028
5.1.2 Child
5.1.3 Adult
5.2 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
5.2.1 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2022
5.2.2 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2023-2028
5.2.3 By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Market Size, 2021 & 2028
6.2 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue & Forecasts
6.2.1 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2022
6.2.2 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2023-2028
6.2.3 By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2028
6.3.2 US Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.3.3 Canada Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.3.4 Mexico Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2028
6.4.2 Germany Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.4.3 France Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.4.4 U.K. Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.4.5 Italy Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.4.6 Russia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.4.7 Nordic Countries Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.4.8 Benelux Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2028
6.5.2 China Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.5.3 Japan Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.5.4 South Korea Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.5.5 Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.5.6 India Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2028
6.6.2 Brazil Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.6.3 Argentina Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2028
6.7.2 Turkey Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.7.3 Israel Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.7.4 Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
6.7.5 UAE Pneumococcal Conjugate Vaccine (PCV) Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.1.4 Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.2.4 GSK Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2017-2022)
7.2.5 GSK Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.3.4 Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.4.4 Merck Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2017-2022)
7.4.5 Merck Key News
7.5 Walvax Biotechnology
7.5.1 Walvax Biotechnology Corporate Summary
7.5.2 Walvax Biotechnology Business Overview
7.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.5.4 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2017-2022)
7.5.5 Walvax Biotechnology Key News
7.6 Royal (Wuxi) Bio-Pharmaceutical
7.6.1 Royal (Wuxi) Bio-Pharmaceutical Corporate Summary
7.6.2 Royal (Wuxi) Bio-Pharmaceutical Business Overview
7.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.6.4 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2017-2022)
7.6.5 Royal (Wuxi) Bio-Pharmaceutical Key News
7.7 Zhifei Biologic
7.7.1 Zhifei Biologic Corporate Summary
7.7.2 Zhifei Biologic Business Overview
7.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.7.4 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2017-2022)
7.7.5 Zhifei Biologic Key News
7.8 Serum Institute of India
7.8.1 Serum Institute of India Corporate Summary
7.8.2 Serum Institute of India Business Overview
7.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Major Product Offerings
7.8.4 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue in Global Market (2017-2022)
7.8.5 Serum Institute of India Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Pneumococcal Conjugate Vaccine (PCV) Market Opportunities & Trends in Global Market
Table 2. Pneumococcal Conjugate Vaccine (PCV) Market Drivers in Global Market
Table 3. Pneumococcal Conjugate Vaccine (PCV) Market Restraints in Global Market
Table 4. Key Players of Pneumococcal Conjugate Vaccine (PCV) in Global Market
Table 5. Top Pneumococcal Conjugate Vaccine (PCV) Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pneumococcal Conjugate Vaccine (PCV) Product Type
Table 9. List of Global Tier 1 Pneumococcal Conjugate Vaccine (PCV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pneumococcal Conjugate Vaccine (PCV) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pneumococcal Conjugate Vaccine (PCV) Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pneumococcal Conjugate Vaccine (PCV) Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pneumococcal Conjugate Vaccine (PCV) Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pneumococcal Conjugate Vaccine (PCV) Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 32. Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 35. GSK Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 38. Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 41. Merck Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), (2017-2022)
Table 42. Walvax Biotechnology Corporate Summary
Table 43. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 44. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), (2017-2022)
Table 45. Royal (Wuxi) Bio-Pharmaceutical Corporate Summary
Table 46. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 47. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), (2017-2022)
Table 48. Zhifei Biologic Corporate Summary
Table 49. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 50. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), (2017-2022)
Table 51. Serum Institute of India Corporate Summary
Table 52. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Offerings
Table 53. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Pneumococcal Conjugate Vaccine (PCV) Segment by Type in 2021
Figure 2. Pneumococcal Conjugate Vaccine (PCV) Segment by Application in 2021
Figure 3. Global Pneumococcal Conjugate Vaccine (PCV) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pneumococcal Conjugate Vaccine (PCV) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pneumococcal Conjugate Vaccine (PCV) Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2021
Figure 8. By Type - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
Figure 12. US Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
Figure 16. Germany Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 17. France Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
Figure 24. China Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 28. India Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
Figure 30. Brazil Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share, 2017-2028
Figure 33. Turkey Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pneumococcal Conjugate Vaccine (PCV) Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
